Joel Lexchin

York University

Professor

4700 Keele Street

Toronto, Ontario M3J 1P3

Canada

SCHOLARLY PAPERS

11

DOWNLOADS
Rank 6,120

SSRN RANKINGS

Top 6,120

in Total Papers Downloads

12,056

SSRN CITATIONS
Rank 34,542

SSRN RANKINGS

Top 34,542

in Total Papers Citations

10

CROSSREF CITATIONS

16

Scholarly Papers (11)

1.

Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs

Journal of Law, Medicine and Ethics, 2013, Vol. 14, No. 3: 590-610
Number of pages: 11 Posted: 20 Jun 2013 Last Revised: 11 Apr 2020
Rowan University School of Osteopathic Medicine, York University and Harvard Medical School
Downloads 9,790 (973)
Citation 1

Abstract:

Loading...

2.

Pharmaceutical Research and Development: What Do We Get for All that Money?

BMJ, 2012, DOI: 10.1136/bmj.e4348
Number of pages: 5 Posted: 10 May 2013 Last Revised: 19 Jun 2013
Donald W. Light and Joel Lexchin
Rowan University School of Osteopathic Medicine and York University
Downloads 1,238 (28,349)
Citation 7

Abstract:

Loading...

pharmaceuticals, pharmaceutical policy, regulation, innovation crisis

3.

'Linkage' Pharmaceutical Evergreening in Canada and Australia

Austrailia and New Zealand Journal of Health Policy, Vol. 1, No. 4, p. 8, June 2007
Number of pages: 11 Posted: 18 May 2009 Last Revised: 18 Jul 2014
Thomas Alured Faunce and Joel Lexchin
Australian National University and York University
Downloads 249 (205,048)

Abstract:

Loading...

Evergreening, patent law, linkage evergreening, pharmaceutical regulation, trade agreements, access to medicines

4.

Structure-Function Analysis of Global Pharmaceutical Linkage Regulations

Minnesota Journal of Law, Science & Technology, Forthcoming
Number of pages: 71 Posted: 14 Nov 2010 Last Revised: 07 Dec 2018
affiliation not provided to SSRN, Pennsylvania State University - Mary Jean and Frank P. Smeal College of Business Administration, Uppsala University - Faculty of Law, University of Leeds, Unaffiliated Authors, University of Calgary - Department of Economics, Unaffiliated Authors, Ali & Associates, York University, Independent and Olivares & Cia
Downloads 159 (308,127)

Abstract:

Loading...

5.

Foreign Free Riders and the High Price of U.S. Medicines

BMJ 2005; 331; 958-960
Number of pages: 4 Posted: 18 May 2013
Donald W. Light and Joel Lexchin
Rowan University School of Osteopathic Medicine and York University
Downloads 141 (339,891)
Citation 1

Abstract:

Loading...

health economics, pharmaceutical prices, affordable drugs

6.

Navigating the Evidence: Communicating Canadian Health Policy in the Media

Number of pages: 355 Posted: 11 Sep 2015
Simone de Beauvoir Institute, Concordia University, University of Manitoba - Department of Community Health Sciences (CHS), EvidenceNetwork.ca, EvidenceNetwork.ca, University of Manitoba, University of Montreal, University of Manitoba, McGill University, Faculty of Nursing - University of Montreal, University of Montreal, University of Western Ontario, Lakehead University, University of Ottawa - Faculty of Law, McMaster University - Department of Economics, University of British Columbia (UBC), University of British Columbia (UBC) - Centre for Health Services and Policy Research, Alberta Bone and Joint Health Institute, University of Alberta, University of Victoria - School of Public Administration, University of British Columbia (UBC), University of British Columbia (UBC) - Centre for Health Services and Policy Research, University of Montreal, University of Toronto, INSEAD, University of Saskatchewan, Government of Nova Scotia, Independent, University of British Columbia (UBC), Family Service Toronto, EvidenceNetwork.ca, University of Toronto - Department of Pediatrics, University of British Columbia - Faculty of Pharmaceutical Sciences, University of Pennsylvania - Department of Sociology, University of Toronto - Saint Michael's Hospital, University of Manitoba - Department of Community Health Sciences (CHS), University of Manitoba - Department of Community Health Sciences (CHS), University of Manitoba, University of Victoria, EvidenceNetwork.ca, University of Toronto - Child Health Evaluative Sciences, University of Manitoba, University of British Columbia (UBC) - Centre for Health Services and Policy Research, University of Northern British Columbia, York University, Carleton University - School of Public Policy and Administration, Sunnybrook Health Sciences Centre, Women’s College Hospital, York University, Freelance Writer, University of Calgary, University of Toronto, University of Toronto - Centre for Addiction and Mental Health (CAMH), University of Manitoba, University of Ottawa, University of Ottawa, McGill University - Institute for Health and Social Policy, University of Southern California - Schaeffer Center for Health Policy and Economics and City University of New York (CUNY) - CUNY School of Public Health at Hunter College
Downloads 116 (393,624)

Abstract:

Loading...

7.

Structure-Function Analysis of Global Pharmaceutical Linkage Regulations

Minnesota Journal of Law, Science & Technology, Vol. 12, No. 2, 2011
Number of pages: 66 Posted: 21 Feb 2015
University of Manitoba - Faculty of Law (deceased), Pennsylvania State University - Mary Jean and Frank P. Smeal College of Business Administration, Uppsala University - Faculty of Law, University of Leeds, Unaffiliated Authors, University of Calgary - Department of Economics, Independent, National Law School of India University, York University, Independent and Olivares & Cia
Downloads 100 (437,687)

Abstract:

Loading...

Global Pharmaceutical Linkage, Structure Function Relationship, Hatch-Waxman Act, NOC Regulations, TRIPS Plus, WTO

8.

The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia

Lexchin J and Gleeson D. (2016) The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia. International Journal of Health Services, 46(4):597-613. doi: 10.1177/0020731416662612
Number of pages: 30 Posted: 25 Oct 2016
Joel Lexchin and Deborah Gleeson
York University and La Trobe University
Downloads 89 (471,844)
Citation 5

Abstract:

Loading...

international trade agreements, pharmaceutical regulation, intellectual property, access to medicines, Trans Pacific Partnership Agreement

9.

Making Evidence Matter in Canadian Health Policy

Number of pages: 291 Posted: 11 Sep 2015
Simone de Beauvoir Institute, Concordia University, University of Manitoba - Department of Community Health Sciences (CHS), EvidenceNetwork.ca, EvidenceNetwork.ca, University of British Columbia (UBC) - Centre for Health Services and Policy Research, University of Manitoba - Department of Community Health Sciences (CHS), University of Victoria, Independent, Lakehead University, University of Toronto - Department of Pediatrics, University of Calgary, Carleton University - School of Public Policy and Administration, University of British Columbia (UBC), University of Manitoba, Simon Fraser University (SFU) - School of Public Policy, University of Regina, University of British Columbia - Faculty of Pharmaceutical Sciences, University of British Columbia (UBC), University of British Columbia (UBC) - Centre for Health Services and Policy Research, University of British Columbia (UBC) - Centre for Health Services and Policy Research, Institute for Clinical Evaluative Sciences (ICES), University of British Columbia - Centre for Health Services and Policy Research, EvidenceNetwork.ca, EvidenceNetwork.ca, EvidenceNetwork.ca, Independent, University of Toronto, Johnson-Shoyama Graduate School of Public Policy, Memorial University of Newfoundland (MNU), McMaster University - Department of Economics, University of Toronto, Pathways to Housing, University of Toronto, University of Toronto, University of Saskatchewan, University of British Columbia (UBC) - Centre for Health Services and Policy Research, Sunnybrook Health Sciences Centre, University of Alberta, University of Alberta, University of Toronto - Saint Michael's Hospital, New York University (NYU), York University, University of Toronto, University of Toronto, University of Calgary - Faculty of Nursing, Freelance Writer, McGill University - Institute for Health and Social Policy, City University of New York (CUNY) - CUNY School of Public Health at Hunter College, Canadian Hospice Palliative Care Association (CHPCA), Queen's University, Independent, University of British Columbia (UBC) - Centre for Health Services and Policy Research, New York University (NYU) and University of Toronto - Saint Michael's Hospital
Downloads 78 (510,806)
Citation 1

Abstract:

Loading...

10.

Evolution of Physician-Industry Relationships in Producing Knowledge of Drug Therapy - Comparison of the United States and Finland

Number of pages: 27 Posted: 04 Apr 2017
Elina Hemminki, Joel Lexchin and Nicolas Rasmussen
Government of the Republic of Finland - National Institute for Health and Welfare, York University and University of New South Wales (UNSW) - School of Humanities & Languages
Downloads 72 (534,459)

Abstract:

Loading...

drug industry, bias, research, history, sponsorship, United States, Finland

11.

Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of COVID-19

(2020) 51(1) International Journal of Health Services at 5-13.
Number of pages: 9 Posted: 16 Feb 2022
York University, Dalhousie University, Dalhousie University - Faculties of Medicine and LawDalhousie University - Faculty of Medicine, University of Oxford - Department for Continuing Education and University of Toronto - Faculty of Law
Downloads 24 (819,356)

Abstract:

Loading...

Clinical trials, pharmaceuticals, drug regulation, pivotal trials, transparency, COVID-19